RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Boston Scientific Corporation
4,800 participants
Nov 19, 2012
OBSERVATIONAL
Conditions
Summary
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use \- and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Eligibility
Inclusion Criteria3
- Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use
- Signed a valid, IRB/EC-approved informed consent form
- years of age or older
Exclusion Criteria2
- Contraindicated for Boston Scientific neurostimulation system
- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Trial stimulation period, followed by permanent implant of a neurostimulation system for subjects with a positive trial outcome
Locations(118)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01719055